Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	16954
Country	United States

Received	2015-02-04 08:09
Peer-Review Started	2015-02-05 20:26
To Make the First Decision	2015-04-10 16:39
Return for Revision	2015-04-15 09:12
Revised	2015-04-24 02:55
Second Decision	2015-05-25 11:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-06-02 17:25
Articles in Press	2015-06-02 17:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-01 16:21
Publish the Manuscript Online	2015-07-14 12:20

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Anti-angiogenic agents in metastatic colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Bhavana Konda, Helen Shum and Lakshmi Rajdev
Funding Agency and Grant Number
Corresponding Author	Lakshmi Rajdev, MD, Department of Medical Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, 1695 Eastchester Road, Bronx, NY 10461, United States. lrajdev@montefiore.org
Key Words	Anti-angiogenic agents; Metastatic colorectal cancer; Targeted agents; Conversion therapy; Colorectal metastasectomy
Core Tip	Colorectal cancer is a major health concern and a leading cause of cancer mortality worldwide. New innovations have provided improved survival in recent years. In this review, we outline the novel anti-angiogenic agents and their respective roles in metastatic colorectal cancer. In addition to three agents approved by the Food and Drug Administration, several alternative anti-angiogenic agents hold promise for use in the metastatic setting.
Publish Date	2015-07-14 12:20
Citation	Konda B, Shum H, Rajdev L. Anti-angiogenic agents in metastatic colorectal cancer. World J Gastrointest Oncol 2015; 7(7): 71-86
URL	http://www.wjgnet.com/1948-5204/full/v7/i7/71.htm
DOI	http://dx.doi.org/10.4251/wjgo.v7.i7.71

Full Article (PDF)	WJGO-7-71.pdf
Full Article (Word)	WJGO-7-71.doc
Manuscript File	16954-Review.docx
Answering Reviewers	16954-Answering reviewers.pdf
Audio Core Tip	16954-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16954-Conflict-of-interest statement.pdf
Copyright License Agreement	16954-Copyright assignment.pdf
Peer-review Report	16954-Peer-review(s).pdf
Scientific Misconduct Check	16954-Scientific misconduct check.pdf
Scientific Editor Work List	16954-Scientific editor work list.pdf